About Us

At Hb-022, we are solving three of the most pressing challenges in drug development: bioavailability, cost-efficiency, and commercialization. With proprietary technologies, a high-impact team, and an AI-powered strategy, we provide a compelling path from discovery to ROI—fast.

1. Enhancing Bioavailability

Poor bioavailability remains one of the key reasons for clinical failure. Multiple studies emphasize that solubility, permeability, and metabolic instability continue to limit drug performance, especially for small molecules. This leads to higher dosages, and resulting in higher side-effects.

We’ve developed proprietary excipients and delivery platforms that significantly enhance systemic drug exposure. Our internal R&D and clinical formulation team has deep expertise in optimizing PK profiles, accelerating success in both early and late-stage development.

2. Reducing Development Costs—With Quality and Proven Execution

Drug development is notoriously expensive, but it doesn’t have to be.

  • We completed a 150-patient Phase II trial for under USD 2 million, inclusive of formulation, API, CMC, and regulatory activities.

  • We’ve applied similar financial discipline to Phase I and Phase III programs, without compromising quality or compliance.

The result: superior capital efficiency, faster timelines, and stronger investor ROI. For pharma partners, this translates into reduced risk and quicker go/no-go decisions for licensing.

3. Enabling Smarter Commercialization with AI

Licensing, valuation, and investor traction are often overlooked, but crucial.

Our proprietary AI valuation platform supports:

  • Real-time modeling of pipeline and product value

  • Optimized deal structuring for licensing and M&A

  • Intelligent matchmaking with investors, CROs, and strategic pharma partners

We enable data-driven decisions, accelerating deal flow and maximizing value creation for all stakeholders.

Let’s Talk

We are actively engaging with:

  • Investors seeking capital-efficient, de-risked biotech assets

  • Pharma partners exploring differentiated molecules or platforms

  • Innovators ready to scale up formulation and clinical execution

If you're interested in unlocking value faster—and smarter—contact us to explore licensing, partnerships, or investment opportunities.

Would you like this formatted into a PDF brochure or web section layout? I can also generate a concise version for slide decks or investor teasers.

Innovation

Empowering future generations through efficient clinical development strategies.

A box of skincare product labeled 'PLANTADEA' is positioned among lush, green tropical leaves. The product is described as a 'BIO BODY CREAM' intended for dry and delicate skin, containing 1% CBD. It is clinically and dermatologically tested, with text in both Italian and English highlighting these features.
A box of skincare product labeled 'PLANTADEA' is positioned among lush, green tropical leaves. The product is described as a 'BIO BODY CREAM' intended for dry and delicate skin, containing 1% CBD. It is clinically and dermatologically tested, with text in both Italian and English highlighting these features.
A sign featuring the word 'CONSULTATION' in bold, black capital letters. Beneath the text, there is Braille marked on a white background, surrounded by a dark wooden frame.
A sign featuring the word 'CONSULTATION' in bold, black capital letters. Beneath the text, there is Braille marked on a white background, surrounded by a dark wooden frame.
A cup of coffee with frothy milk sits on a saucer accompanied by a teaspoon. Next to it is a magazine or brochure titled 'Medical Conference Planning' featuring an image of two people in conversation, likely in a professional or clinical setting.
A cup of coffee with frothy milk sits on a saucer accompanied by a teaspoon. Next to it is a magazine or brochure titled 'Medical Conference Planning' featuring an image of two people in conversation, likely in a professional or clinical setting.
A male doctor wearing a white lab coat is attentively administering medical care to a patient. The patient, who is seated in a hospital chair, is receiving treatment through a port in his chest. A female healthcare professional stands nearby, observing and providing support.
A male doctor wearing a white lab coat is attentively administering medical care to a patient. The patient, who is seated in a hospital chair, is receiving treatment through a port in his chest. A female healthcare professional stands nearby, observing and providing support.
A group of people are in a meeting room. One person is standing and pointing at a whiteboard covered with diagrams and notes, while holding a piece of paper. Two other individuals are seated at a table with open laptops in front of them, appearing to be engaged in the presentation.
A group of people are in a meeting room. One person is standing and pointing at a whiteboard covered with diagrams and notes, while holding a piece of paper. Two other individuals are seated at a table with open laptops in front of them, appearing to be engaged in the presentation.

Know More or Talk to an Expert

Innovation

Advancing clinical development for a healthier future.

Quality

Trust

akash.m@hb-022.com

© 2025. All rights reserved.